PregLem
AcquiredGeneva, Switzerland · Founded 2006 · $75.8M raised
- Headquarters
- Geneva
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Website
- preglem.com
- Total Funding
- $75.8M
- Last Round
- $42.0M Series BJan 2012
- Rounds
- 2
- Acquisition Date
- Jan 2010
About
PregLem was a Swiss specialty biopharmaceutical company founded in 2006 and headquartered in Geneva, Switzerland, focused on reproductive medicine and gynecological therapies. The company developed intellectual property and conducted clinical and pre-clinical development of compounds targeting conditions such as uterine fibroids and endometriosis. PregLem was acquired by Hungarian pharmaceutical firm Gedeon Richter in October 2010, after which it continued operations as a Richter subsidiary focused on women's health drug development and commercialization in Europe.
Summary
PregLem is a Biotech company based in Geneva, Switzerland, founded in 2006. It has raised $75.8M in total across 2 rounds, most recently a $42.0M Series B round in Jan 2012. Investors include Sofinnova Partners, Gedeon Richter and MVM Partners.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2012
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company